Search by Drug Name or NDC

    NDC 49281-0564-10 QUADRACEL 20; 5; 3; 20; 5; 15; 29; 7; 26 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL Details

    QUADRACEL 20; 5; 3; 20; 5; 15; 29; 7; 26 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL

    QUADRACEL is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXO.

    Product Information

    NDC 49281-0564
    Product ID 49281-564_36dac28e-f95b-4c27-a9f7-0d3a37e67bf3
    Associated GPIs 18990004351820 1899000435E620
    GCN Sequence Number 083062
    GCN Sequence Number Description diph,pertus(acel),tet,polio/PF VIAL 15-48-5-62 INTRAMUSC
    HIC3 W7Z
    HIC3 Description VACCINE/TOXOID PREPARATIONS,COMBINATIONS
    GCN 51903
    HICL Sequence Number 035666
    HICL Sequence Number Description DIPHTHERIA, PERTUSSIS(ACELL),TETANUS,POLIO VACCINE/PF
    Brand/Generic Brand
    Proprietary Name QUADRACEL
    Proprietary Name Suffix n/a
    Non-Proprietary Name diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
    Product Type VACCINE
    Dosage Form INJECTION, SUSPENSION
    Route INTRAMUSCULAR
    Active Ingredient Strength 20; 5; 3; 20; 5; 15; 29; 7; 26
    Active Ingredient Units ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL
    Substance Name BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXO
    Labeler Name Sanofi Pasteur Inc.
    Pharmaceutical Class Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immuni
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125525
    Listing Certified Through 2024-12-31

    Package

    NDC 49281-0564-10 (49281056410)

    NDC Package Code 49281-564-10
    Billing NDC 49281056410
    Package 10 VIAL, SINGLE-USE in 1 PACKAGE (49281-564-10) / .5 mL in 1 VIAL, SINGLE-USE (49281-564-58)
    Marketing Start Date 2015-03-24
    NDC Exclude Flag N
    Pricing Information N/A